US EditionThe Rise Of STAT6 Degraders - Data Intelligence
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.2 Articles
2 Articles
The Rise Of STAT6 Degraders - Data Intelligence
Newsletter Signup – Under Article / In Page “*” indicates required fields For years, STAT6, a key transcription factor in allergic diseases like asthma and atopic dermatitis, was considered off-limits. Traditional small molecules couldn’t get a grip on it. There were no neat pockets to bind, no enzymes to inhibit. Yet STAT6 plays a central role in Th2-driven diseases. Activated by interleukins 4 and 13, it drives the production of IgE, fuels in…
From undruggable to oral therapy: The rise of STAT6 degraders
Delve into the STAT6 degrader technology and what it could bring to inflammatory and allergic disease treatment. The post From undruggable to oral therapy: The rise of STAT6 degraders appeared first on Labiotech.eu. © Labiotech UG and Labiotech.eu. Unauthorized use and/or duplication of this material without express and written permission from this site’s author and/or owner is strictly prohibited. Excerpts and links may be used, provided that f…
Coverage Details
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
To view factuality data please Upgrade to Premium
